SOPHiA GENETICS SA SOPH 深 滬
已收盤 06-18 16:00:00 美东时间
5.46
+0.220
+4.20%
華盛通- 最 高5.49
- 今 開5.35
- 成交量 44.51万股
- 最 低 5.18
- 昨 收 5.24
- 總市值 3.92亿
- 52周最高 5.70
- 市盈率 靜 --
- 換手率 0.62%
- 52周最低 2.81
- 委 比 42.62%
- 總股本 7179.04万
- 歷史最高 19.80
- 量 比 1.13
- 振 幅 5.92%
- 歷史最低 1.685
- 每 手 1
- 風險率 0.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Stock Market Today: Dow Jones Futures Tumble, S&P 500 Gains As Investors Await FOMC Decision—Amkor, La-Z-Boy In Focus
U.S. stock futures were mixed on Wednesday, as the Dow Jones fell, while the Nasdaq 100 and S&P 500 advanced, following Tuesday’s mixed close. Investors are waiting for the Federal Open Market Committee decision on interest rates, slated to be announced during the afternoon, with Kevin Warsh as the ...
06-17 17:29
CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects CarMax Inc. (NYSE:KMX) to post quarterly earnings at 94 cents per share on revenue of $7.41 billion before the opening bell, according to data f...
06-17 14:50
SOPHiA GENETICS Commences Ordinary Shares Offering; Terms Undisclosed
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten public offering of its ordinary shares. The Company also expects to grant the underwriters an option to purchase up to an additional 15% of the ordinary shares ...
06-17 04:22
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed u...
06-17 04:20
美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
BTIG Reiterates Buy on Sophia Genetics, Maintains $8 Price Target
BTIG analyst Mark Massaro reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $8 price target.
06-15 20:09
SOPHiA GENETICS Inks MoU With Memorial Sloan Kettering Cancer Center To Form JV Between Two Institutions
SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the
06-04 20:15
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
BTIG Reiterates Buy on Sophia Genetics, Maintains $8 Price Target
BTIG analyst Mark Massaro reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $8 price target.
05-06 18:15
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
